Zobrazeno 1 - 10
of 4 082
pro vyhledávání: '"detrusor overactivity"'
Publikováno v:
Vestnik Urologii, Vol 12, Iss 4, Pp 50-56 (2024)
Introduction. Overactive bladder (OAB) remains one of the most difficult-to-treat conditions in neurourology. The number of patients seeking help for OAB symptoms does not decrease each year, while a pathogenetic treatment has not yet been developed.
Externí odkaz:
https://doaj.org/article/dee5bfc526a544f78ceb51b648fc9f96
Publikováno v:
International Journal of Women's Health, Vol Volume 16, Pp 1049-1053 (2024)
Giulia Marchetti,1 Annika Taithongchai,2 Dudley Robinson2 1Urogynaecology Department, Irmandade de Misericórdia da Santa Casa de São Paulo, Sao Paulo, Brazil; 2Urogynaecology Department, King’s College Hospital, London, UKCorrespondence: Dudley R
Externí odkaz:
https://doaj.org/article/0686f4150af043a9b134428746dde4c5
Autor:
Johnny S. Su, Rose Khavari
Publikováno v:
Continence Reports, Vol 11, Iss , Pp 100054- (2024)
Purpose:: While intradetrusor botulinum neurotoxin (BoNT) injection is a well-established treatment of neurogenic detrusor overactivity, its administration in individuals with complex genitourinary (GU) reconstruction can be difficult. The objective
Externí odkaz:
https://doaj.org/article/aa83e539aa4a47c5b11ce2ac4d71e412
Autor:
Chie Nakai, Kosei Miwa, Akane Yamaguchi, Yasumichi Takeuchi, Masami Yamaguchi, Yasuhide Kitagawa, Takuya Koie
Publikováno v:
IJU Case Reports, Vol 7, Iss 3, Pp 247-249 (2024)
Introduction We report a case of refractory overactive bladder with cough‐associated detrusor overactivity treated by onabotulinumtoxin A. Case presentation A 79‐year‐old woman who underwent mid‐urethral sling surgery 8 years ago complained m
Externí odkaz:
https://doaj.org/article/903e806f507248a79b045bf2d7684f33
Publikováno v:
Continence Reports, Vol 10, Iss , Pp 100048- (2024)
A 42-year-old woman was referred by neurology colleagues to our outpatient urology clinics. She presented with a non-monosymptomatic secondary enuresis, which started at 20 years of age When she was twenty-two she presented a single episode of a gene
Externí odkaz:
https://doaj.org/article/6717a5caf9064d6cb901dd9920fee18c
Publikováno v:
Continence, Vol 10, Iss , Pp 101314- (2024)
Background:: Overactive Bladder Syndrome (OAB) affects individuals across all ages and genders, reducing quality of life. Although Transcutaneous Posterior Tibial Nerve Stimulation (TTNS) is an effective treatment, its acute effects on OAB remain und
Externí odkaz:
https://doaj.org/article/7c237b47e5954f249239421cb5e3893e
Autor:
Karl-Erik Andersson
Publikováno v:
Continence, Vol 10, Iss , Pp 101317- (2024)
The history of TRP channels and bladder started in the 1980-ies with the studies of Maggi and collaborators, who created the basis for using capsaicin and other vanilloids in LUT disorders. This narrative review gives a brief history of bladder TRP c
Externí odkaz:
https://doaj.org/article/21f165e4d18845b5bdda5c80cc03b515
Autor:
Daniele Bianchi, Matteo Ricci, Valerio Iacovelli, Simone Pletto, Eleonora Rosato, Roberto Miano, Enrico Finazzi Agrò
Publikováno v:
Continence, Vol 10, Iss , Pp 101227- (2024)
Aim:: Intravesical onabotulinum toxin A (BTX) injection is a widely recognized treatment for idiopathic detrusor overactivity (DO) and neurogenic detrusor overactivity (NDO) refractory to adjustments in oral medications.The primary end point of our s
Externí odkaz:
https://doaj.org/article/39857d31f50f4424baad1f64bba0d3bc
Autor:
Mohammad Sajjad Rahnama'i, Amin Bagheri, Elham Jahantabi, Hanieh Salehi-Pourmehr, Hadi Mostafaei, Brigitte Schurch, Aida Javan Balegh Marand, Sakineh Hajebrahimi
Publikováno v:
Asian Journal of Urology, Vol 11, Iss 1, Pp 93-98 (2024)
Objective: Only a few numbers of studies have been published on the use of abobotulinumtoxinA (Dysport®) in idiopathic detrusor overactivity (IDO). This study reported the long-term follow-up of women with IDO who were treated with intravesical Dysp
Externí odkaz:
https://doaj.org/article/b4cbe54a9cdf474f875c249610415cb0
Autor:
Ping-Hsuan Yu, Chung-Cheng Wang
Publikováno v:
Toxins, Vol 16, Iss 8, p 343 (2024)
Despite the efficacy of onabotulinumtoxinA, its safety profile remains a concern. This meta-analysis reviewed the major adverse events (AEs) associated with intravesical onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity (
Externí odkaz:
https://doaj.org/article/3d9b6dd403ce416ba712e18e425f68a3